(Q39839534)

English

Intracranial elimination of human glioblastoma brain tumors in nude rats using the bispecific ligand-directed toxin, DTEGF13 and convection enhanced delivery

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Intracranial elimination of human glioblastoma brain tumors in nude rats using the bispecific ligand-directed toxin, DTEGF13 and convection enhanced delivery (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

convection-enhanced delivery

0 references

1 reference

based on heuristic

inferred from title

Daniel A Vallera

7

object named as

Daniel A Vallera

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

author name string

Seunguk Oh

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

John R Ohlfest

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Deborah A Todhunter

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Vincent D Vallera

4

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Walter A Hall

5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Hua Chen

6

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

publication date

11 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

95

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

331-342

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Lessons learned in the development of targeted therapy for malignant gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

A bispecific immunotoxin (DTAT13) targeting human IL-13 receptor (IL-13R) and urokinase-type plasminogen activator receptor (uPAR) in a mouse xenograft model

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Genetic alteration of a bispecific ligand-directed toxin targeting human CD19 and CD22 receptors resulting in improved efficacy against systemic B cell malignancy

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Increasing anticarcinoma activity of an anti-erbB2 recombinant immunotoxin by the addition of an anti-EpCAM sFv.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Anti-glioblastoma effect of a recombinant bispecific cytotoxin cotargeting human IL-13 and EGF receptors in a mouse xenograft model

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

A bispecific recombinant cytotoxin (DTEGF13) targeting human interleukin-13 and epidermal growth factor receptors in a mouse xenograft model of prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Genetically designing a more potent antipancreatic cancer agent by simultaneously co-targeting human IL13 and EGF receptors in a mouse xenograft model.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Expression of a restrictive receptor for interleukin 13 is associated with glial transformation.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Interleukin-13 receptor as a unique target for anti-glioblastoma therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Intratumoral immunotoxin treatment of human malignant brain tumors in immunodeficient animals

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Diphtheria Toxin−Epidermal Growth Factor Fusion Protein and Pseudomonas Exotoxin−Interleukin 13 Fusion Protein Exert Synergistic Toxicity against Human Glioblastoma Multiforme Cells

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Imaging brain structure and function, infection and gene expression in the body using light

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Intracranial therapy of glioblastoma with the fusion protein DTAT in immunodeficient mice

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Intracranial therapy of glioblastoma with the fusion protein DTIL13 in immunodeficient mice.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Interstitial infusion of IL13-PE38QQR in the rat brain stem

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Immunotoxin treatment targeted to the high-molecular-weight melanoma-associated antigen prolonging the survival of immunodeficient rats with invasive intracranial human glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Limitations of the C6/Wistar rat intracerebral glioma model: implications for evaluating immunotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

An immunotoxin with greatly reduced immunogenicity by identification and removal of B cell epitopes

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Targeting cancer micrometastases with monoclonal antibodies: a binding-site barrier

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Improved distribution of small molecules and viral vectors in the murine brain using a hollow fiber catheter.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Vascular and interstitial barriers to delivery of therapeutic agents in tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Interleukin 13 elicits a subset of the activities of its close relative interleukin 4.

1 reference

https://api.crossref.org/works/10.1007%2FS11060-009-9932-2

21 January 2018

Depletion of the helper/inducer (memory) T cell subset using a bispecific antibody-toxin conjugate directed against CD4 and CD29.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19517064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/19517064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-13: characterization and biologic properties.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19517064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interstitial diphtheria toxin-epidermal growth factor fusion protein therapy produces regressions of subcutaneous human glioblastoma multiforme tumors in athymic nude mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19517064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19517064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-T-cell reagents for human bone marrow transplantation: ricin linked to three monoclonal antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/19517064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bispecific anti-CD22/anti-CD3-ricin A chain immunotoxin is cytotoxic to Daudi lymphoma cells but not T cells in vitro and shows both A-chain-mediated and LAK-T-mediated killing

1 reference

https://pubmed.ncbi.nlm.nih.gov/19517064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increasing volume of distribution to the brain with interstitial infusion: dose, rather than convection, might be the most important factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/19517064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A modeling analysis of monoclonal antibody percolation through tumors: a binding-site barrier.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19517064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeted therapy with immunotoxins in a nude rat model for leptomeningeal growth of human small cell lung cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19517064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An in vivo model to study immunotoxin-induced vascular leak in human tissue.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19517064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The spatial distribution of immunotoxins in solid tumors: assessment by quantitative autoradiography

1 reference

https://pubmed.ncbi.nlm.nih.gov/19517064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotoxins and vascular leak syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/19517064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular modification of a recombinant, bivalent anti-human CD3 immunotoxin (Bic3) results in reduced in vivo toxicity in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/19517064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diphtheria toxin: mode of action and structure

1 reference

https://pubmed.ncbi.nlm.nih.gov/19517064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier

1 reference

https://pubmed.ncbi.nlm.nih.gov/19517064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A bivalent single-chain antibody-toxin specific for ErbB-2 and the EGF receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/19517064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth factor receptor expression varies among high-grade gliomas and normal brain: epidermal growth factor receptor has excellent properties for interstitial fusion protein therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19517064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of recombinant immunotoxin RFB4(dsFv)-PE38 (BL22) in patients with B-cell malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/19517064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structure/function analysis of interleukin-2-toxin (DAB486-IL-2). Fragment B sequences required for the delivery of fragment A to the cytosol of target cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19517064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell

1 reference

https://pubmed.ncbi.nlm.nih.gov/19517064

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-009-9932-2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39839534&oldid=2203208777"